Menu
Drugmakers AstraZeneca and Sanofi updated their 340B contract pharmacy policies
Drugmakers AstraZeneca and Sanofi updated their 340B contract pharmacy policies in late November.

AstraZeneca Adds Drug to 340B Contract Pharmacy Restrictions, Sanofi Ends Oklahoma Exemption

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Two major drugmakers updated their 340B contract pharmacy policies in late November, with one adding an asthma treatment to its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Drugmakers Sue Over 340B Contract Pharmacy Access Laws in Rhode Island and Vermont, Citing Rebate Pilot Conflicts

Puma Biotechnology 40th Drugmaker to Enact 340B Contract Pharmacy Restrictions, 2nd to Use Kalderos’ Truzo Platform

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live